Skip to main content

Table 2 IgM anti-PC autoantibody baseline distribution (median) according to characteristics of patients with rheumatoid arthritis

From: Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

  

IgM anti-PC, U/ml, baseline distribution

n

Median

p value

CV events during follow-up

Non-CV

512

64.19

0.020

CV

141

51.79

 

Age, years

< 55

317

69.21

< 0.001

> 55

336

53.20

 

Sex

Female

443

64.81

< 0.001

Male

210

52.90

 

BMI, kg/m2

< 25

334

67.28

0.002

25–30

235

55.02

 

> 30

84

47.56

 

Smoking

Non-smoker

463

58.34

0.070

Current smoker

190

65.0

 

Hypertension

Non-hypertensive

554

62.68

0.013

Hypertensive

99

47.91

 

Diabetes mellitus

Non-diabetic

627

60.89

0.631

Diabetic

26

56.98

 

Hyperlipidemia

Non-hyperlipidemic

648

60.88

0.658

Hyperlipidemic

5

48.17

 

Seropositive

Seropositive

441

63.59

0.190

Seronegative

212

55.35

 

DAS28 remission at 1 year

Remission

237

61.11

0.895

Non-remission

416

60.10

 

DAS28 remission at 2 years

Remission

256

61.73

0.223

Non-remission

397

57.97

 
  1. Statistical significance was tested with the Mann-Whitney U test
  2. BMI, body mass index; DAS28, Disease Activity Score 28-joint count; DAS28 remission, if DAS28 < 2.6; HAQ, Health Assessment Questionnaire; Anti-PC, phosphorylcholine antibodies
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us